M D
Private Practice · Faculty of medicine, Ain Shams university · Fatih Sultan Mehmet Training and Research Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name M D as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:10 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07047651 · Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.Dr. Stavroula Rakitzi · active not recruiting · Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder · study director
- Ph1NCT06993662 · The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.Rakitzi, Stavroula · completed · Anxiety, Depression, Obsessive-compulsive Disorder · study director
- N/ANCT06951113 · Prevalence of Mental Health Disorders in Junior Anesthetists and IntensivistsAin Shams University · not yet recruiting · Mental Disorder · study director
- N/ANCT06848062 · Validation of the Paris (Functional Coccydynia Effect) Pain QuestionnaireFatih Sultan Mehmet Training and Research Hospital · completed · Coccydynia, Coccyx Disorder, Coccyx Injury · principal investigator
- N/ANCT06763120 · Post Operative Atrial Fibrillation Post Cardiac Surgery ( CABG and VALVE REPLACEMENT )Assiut University · not yet recruiting · Post Operative Atrial Fibrillation · study chair
- N/ANCT06676527 · Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell CarcinomaJinling Hospital, China · recruiting · Neoplasms, Kidney Neoplasms, Urologic Neoplasms · study chair
- Ph3NCT06413121 · Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPVSerum Institute of India Pvt. Ltd. · completed · Diptheria Immunization, Tetanus Immunization, Pertussis Immunization · principal investigator
- Early Ph1NCT06184321 · Alteplase Through an Indwelling Pleural Catheter for the Management of Symptomatic Septated Malignant Pleural EffusionM.D. Anderson Cancer Center · recruiting · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm · principal investigator
- N/ANCT06121232 · Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility StudyM.D. Anderson Cancer Center · recruiting · Neuropathy;Peripheral · principal investigator
- Ph2NCT06113302 · A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)M.D. Anderson Cancer Center · active not recruiting · Myelodysplastic Syndromes · principal investigator
- N/ANCT06109870 · Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer ScreeningM.D. Anderson Cancer Center · recruiting · HPV · principal investigator
- Ph2NCT06108232 · Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular LymphomaM.D. Anderson Cancer Center · recruiting · Follicular Lymphoma, Tumor · principal investigator
- Ph1/Ph2NCT06105554 · Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple MyelomaM.D. Anderson Cancer Center · recruiting · Multiple Myeloma · principal investigator
- Ph2NCT06085625 · A Randomized Control Trial for Patient Reported Outcomes and Safety in Outpatient Thyroid LobectomyM.D. Anderson Cancer Center · recruiting · Thyroid Lobectomy · principal investigator
- Ph3NCT06065449 · A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone MetastasesM.D. Anderson Cancer Center · recruiting · Bone Metastases · principal investigator
- Ph1/Ph2NCT06066359 · Ph I/II Trial of Cord Blood-derived NK Cells With NY-ESO-1 TCR/IL-15 for R/R MyelomaM.D. Anderson Cancer Center · recruiting · Relapsed/Refractory Myeloma · principal investigator
- Ph1NCT06066424 · Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)M.D. Anderson Cancer Center · recruiting · Solid Tumors · principal investigator
- Ph1/Ph2NCT06065462 · Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100M.D. Anderson Cancer Center · recruiting · Ovarian Clear Cell Carcinoma · principal investigator
- Ph1/Ph2NCT06066437 · NeoAdjuvant Theranostic Lutetium Study: The Nautilus TrialM.D. Anderson Cancer Center · recruiting · Prostate Cancer · principal investigator
- Ph2NCT06053658 · Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaM.D. Anderson Cancer Center · recruiting · Renal Cell Carcinoma · principal investigator
- Ph2NCT06046482 · Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell CarcinomaM.D. Anderson Cancer Center · terminated · Head Neck, Squamous Cell Carcinoma of Head and Neck · principal investigator
- Ph3NCT06041477 · Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCCSun Yat-sen University · recruiting · Hepatocellular Carcinoma, Chemotherapy Effect, Chemotherapeutic Toxicity · principal investigator
- N/ANCT05850598 · Effect of rTMS of the Cerebellum on Parkinson's DiseaseJiangsu Province Nanjing Brain Hospital · completed · Parkinson Disease, Transcranial Magnetic Stimulation · principal investigator
- N/ANCT05636410 · Ultrasound Assessment of the Larynx and Trachea in the Neonatal PeriodPrincess Anna Mazowiecka Hospital, Warsaw, Poland · completed · Larynx, Trachea · study chair
- N/ANCT05588180 · The Ratio Of Femoral Vein Diameter To Femoral Artery Diameter With Pulse Pressure Variation As A Diagnostic ToolFayoum University Hospital · completed · Mechanically Ventilated Patients · principal investigator
- Ph3NCT04943692 · Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 DiabetesLaboratorios Silanes S.A. de C.V. · suspended · Type 2 Diabetes · principal investigator
- N/ANCT04747626 · B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk RepairEric Roselli, M. D. · recruiting · Thoracic Aortic Aneurysm, Aortic Dissection, Congenital Aortic Anomaly · principal investigator
- N/ANCT04729933 · Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClipsamir kapadia · active not recruiting · Heart Failure, Mitral Regurgitation · principal investigator
- Ph2NCT04704505 · Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Prostate Adenocarcinoma, Metastatic Prostate Adenocarcinoma, Castration-resistant · principal investigator
- N/ANCT04688970 · Personalized Neurorehabilitative Precision Medicine - From Data to TherapiesUniversity Hospital Tuebingen · unknown · Stroke, Acute, Outcome, Improvement, Rehabilitation · principal investigator
- Ph2NCT04618744 · A Study to Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)Oramed, Ltd. · completed · Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis · study director
- Ph2NCT04564846 · A Study to Evaluate the Effect of ORMD-0801 in Patients With Type 2 Diabetes MellitusOramed, Ltd. · completed · Diabetes Mellitus, Type 2 · principal investigator
- N/ANCT04520282 · Hemostatic Variables In Snakebite StudyJubilee Mission Medical College and Research Institute · completed · Snake Bites, Coagulopathy, Consumption · principal investigator
- N/ANCT04492865 · MSCT Chest in Suspected COVID-19 PatientsAssiut University · unknown · COVID-19 · principal investigator
- Ph2NCT04399980 · Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammationThe Cleveland Clinic · completed · COVID 19, SARS-CoV 2, Pneumonia · principal investigator
- Ph2NCT04365153 · Canakinumab in Covid-19 Cardiac Injury (The Three C Study)The Cleveland Clinic · completed · COVID-19, SARS-CoV 2 · principal investigator
- N/ANCT04342728 · Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc SupplementationThe Cleveland Clinic · completed · COVID, Corona Virus Infection · principal investigator
- N/ANCT04264182 · STandardized Ultra-conservative Or Physician-directed ICD Programming for Continuous Flow LVAD SupportThe Cleveland Clinic · terminated · Heart Failure, Systolic, Left Ventricular Assist Device, ICD · principal investigator
- N/ANCT04126018 · Comparative Imaging Assessment of Valvular Heart DiseaseThe Cleveland Clinic · recruiting · Valve Heart Disease, Aortic Stenosis, Aortic Regurgitation · principal investigator
- N/ANCT04116684 · Digital Home Blood Pressure Monitoring in Type B Aortic Dissection PatientsThe Cleveland Clinic · terminated · Aortic Dissection, Hypertension · principal investigator
- N/ANCT04080492 · A Cardiac Disease Quality of Life StudyThe Cleveland Clinic · terminated · Hypertrophic Obstructive Cardiomyopathy, Thoracic Aortic Dilatation, Heart Disease Caused by Ionising Radiation · principal investigator
- Ph1/Ph2NCT04037254 · Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringNRG Oncology · completed · Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 · principal investigator
- Ph2NCT03989609 · Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic ShockKasr El Aini Hospital · completed · Septic Shock · study director
- N/ANCT03986281 · A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide SmartwatchThe Cleveland Clinic · completed · Hypertension, Cardiac Disease, Surgery · principal investigator
- N/ANCT03884634 · Efficacy of the Dabir Surfaces Micropressure Overlay for Decubitus Ulcer Prevention During Cardiac SurgeryThe Cleveland Clinic · completed · Pressure Ulcer, Pressure Injury · principal investigator
- N/ANCT03805802 · Influence of a Liquid Oat Bran Product on Blood Glucose in Patients With Poorly Controlled Type 2 DiabetesStoffwechselzentrum Rhein - Pfalz · completed · Diabetes Mellitus, Type 2, Obesity, Overweight · principal investigator
- N/ANCT03800199 · The Validity and Reliability of the Turkish Version of the Combined Index of Severity of FibromyalgiaEuropean University of Lefke · unknown · Fibromyalgia · principal investigator
- N/ANCT03705910 · Effects of Mobilization and Perceptive Rehabilitation on Patients With Fibromyalgia SyndromeEuropean University of Lefke · completed · Fibromyalgia · principal investigator
- N/ANCT03702465 · Assessment of the Impact of a Personalised Nutrition Intervention in Impaired Glucose RegulationImperial College London · completed · Pre Diabetes · principal investigator
- N/ANCT03687619 · Cognitive Orientation to Daily Occupational Performance and Conductive Education Approaches on Down SyndromeEastern Mediterranean University · completed · Down Syndrome, Trisomy 21 · principal investigator
- N/ANCT03649009 · Thiamine As An Adjuvant Therapy For Hyperlactatemia In Septic Shock PatientsUniversiti Kebangsaan Malaysia Medical Centre · unknown · Hyperlactatemia · principal investigator
- N/ANCT03532685 · Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow upUniversity of Sao Paulo General Hospital · unknown · Severe Asthma, Obesity · study director
- Ph2NCT03467932 · A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes MellitusOramed, Ltd. · completed · T2DM (Type 2 Diabetes Mellitus) · principal investigator
- N/ANCT03106116 · Efficacy of Enhanced External Counterpulsation on Ventricular FunctionSun Yat-sen University · completed · Coronary Heart Disease · principal investigator
- N/ANCT03102502 · Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and StatusSun Yat-sen University · completed · Coronary Heart Disease · principal investigator
- Ph2NCT02954601 · A Study of Single and Multiple Doses of Oral Insulin or Placebo in Subjects With Type 2 Diabetes MellitusOramed, Ltd. · completed · Type 2 Diabetes Mellitus · principal investigator
- N/ANCT02890212 · Selenium as Augmentation Treatment for Sertraline Resistant Major DepressionUniversity of Sao Paulo General Hospital · suspended · Major Depression · principal investigator
- Ph4NCT02883595 · Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for SepsisSun Yat-sen University · completed · Sepsis · principal investigator
- Ph3NCT02867267 · The Efficacy and Safety of Ta1 for SepsisSun Yat-sen University · completed · Sepsis · principal investigator
- N/ANCT02856789 · Determination of Fibrin Activity in Plasma on STA-R® PrototypeDiagnostica Stago R&D · completed · Blood Coagulation Disorders, Thrombotic Disorders, Hemorrhagic Disorders · principal investigator
- N/ANCT02816827 · A Study to Evaluate Efficacy of IP on Alertness and Mental FatigueVedic Lifesciences Pvt. Ltd. · completed · Mental Fatigue · principal investigator
- Ph1/Ph2NCT02762474 · Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal CancerTianjin Medical University Cancer Institute and Hospital · unknown · Esophageal Cancer · principal investigator
- N/ANCT02761772 · Early Pregnancy Cohort and Preimplantation FactorNordsjaellands Hospital · completed · Luteal Phase, Biomarkers, Abortion, Spontaneous · principal investigator
- Ph1/Ph2NCT02737462 · Phase 1/2 Study of CG200745 PPA for Myelodysplastic SyndromeCrystalGenomics, Inc. · unknown · Myelodysplastic Syndrome · principal investigator
- N/ANCT02718729 · Anastomotic Leakage Following Laparoscopic Resection for Rectal CancerMansoura University · completed · Anastomotic Leakage · principal investigator
- Ph2NCT02684227 · Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial CancerM.D. Anderson Cancer Center · completed · Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7 · principal investigator
- Ph2NCT02665936 · Effect of Epidural Dexamethasone on Labor AnalgesiaKasr El Aini Hospital · unknown · Labor · principal investigator
- Ph1NCT02620982 · ARIES for Vasculogenic Erectile DysfunctionDornier MedTech Systems · completed · Erectile Dysfunction, Sexual Dysfunction, Physiological · principal investigator
- N/ANCT02529384 · Multiple B-value Diffusion-weighted Imaging(DWI) in Evaluation of Breast LesionsTang-Du Hospital · unknown · Breast Neoplasms, DWI · study director
- Ph2NCT02494700 · Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell LymphomaM.D. Anderson Cancer Center · active not recruiting · Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2 Follicular Lymphoma · principal investigator
- N/ANCT02486471 · Hemostatic Procedure After Biopsy of the CervixZydolab - Institute of Cytology and Immune Cytochemistry · completed · Uterine Cervical Dysplasia · principal investigator
- N/ANCT02470845 · Trial of Tian Jiu Therapy for Allergic RhinitisHong Kong Baptist University · completed · Allergic Rhinitis (AR) · principal investigator
- Ph3NCT02460887 · The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRTSun Yat-sen University · active not recruiting · Nasopharyngeal Carcinoma · principal investigator
- N/ANCT02440451 · Rt-fMRI NF Intervention Study in ASDUniversity of Coimbra · completed · Autism Spectrum Disorder · principal investigator
- N/ANCT02340546 · Trajectory Changes of Coronary Sinus Lead Tip and Cardiac Resynchronization Therapy OutcomeCorrado Tomasi · completed · Heart Failure, Left-Sided Heart Failure, Ventricular Dysfunction · principal investigator
- Ph2NCT02309437 · Early Use of Opioid in Radiation MucositisAffiliated Cancer Hospital & Institute of Guangzhou Medical University · completed · Nutrition Disorders, Quality of Life · study chair
- Ph4NCT02256969 · Intraductal Meibomian Gland Probing TrialJoseph B. Ciolino, MD · completed · Meibomian Gland Dysfunction · principal investigator
- N/ANCT02220530 · Sedation Effect on the Global Quality ColonoscopyHospital San Juan de Dios Tenerife · unknown · Ambulatory Patients Referred for a First-time Colonoscopy · principal investigator
- N/ANCT02215902 · Safety Study of the Aethlon HemopurifierAethlon Medical Inc. · terminated · End Stage Renal Disease, Hepatitis C Infection · principal investigator
- N/ANCT02124031 · Mexican Initiative of Patients With Osteoarthritis and Rheumatoid Arthritis (IMPACTAR)Iniciativa Mexicana de Pacientes con Osteoartritis y Artritis Reumatoide · completed · Physical Disability, Joint Function Disorder, Axis IV Problems Economic · principal investigator
- Ph4NCT02121951 · Quadratus Lumborum Block for Percutaneous NephrostomyNational Cancer Institute, Egypt · withdrawn · Nephrostomy; Complications, Upper Urinary Tract Dilatation and Obstruction, Regional Anesthesia Morbidity · study director
- Ph4NCT01990690 · Role of Antioxidants in Unexplained Oligohydramnios,A Randomized TrialWoman's Health University Hospital, Egypt · completed · Oilgohydramnios · principal investigator
- N/ANCT01921621 · Proficiency Based Training in Surgery - Employing An Arthroscopic Bankart RepairArthroscopy Association of North America · completed · Study Focus: Simulation and Proficiency Based Training · principal investigator
- Ph4NCT01896492 · Clomiphene Plus N-acetyl Cysteine for Induction of Ovulation in Newly Diagnosed Pcos.Woman's Health University Hospital, Egypt · completed · PCOS · principal investigator
- Ph2NCT01889667 · Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)Oramed, Ltd. · completed · Diabetes Mellitus Type 2 · study director
- N/ANCT01863121 · Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver CirrhosisSir Ganga Ram Hospital · unknown · Cirrhosis · principal investigator
- Ph1NCT01831700 · Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting ConditionsIPCA Laboratories Ltd. · completed · Fasting · principal investigator
- Ph1NCT01827878 · Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed ConditionsIPCA Laboratories Ltd. · completed · Fed · principal investigator
- N/ANCT01815593 · The Value of Enhanced External Counterpulsation on Erectile DysfunctionFirst Affiliated Hospital, Sun Yat-Sen University · unknown · Erectile Dysfunction · study director
- N/ANCT01815697 · Effect of Enhanced External Counterpulsation on Lower Urinary Tract SymptomsFirst Affiliated Hospital, Sun Yat-Sen University · unknown · Lower Urinary Tract Symptoms · study director
- Ph1/Ph2NCT01809275 · Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's DiseaseQu Biologics Inc. · completed · Crohn's Disease, Inflammatory Bowel Disease · study director
- N/ANCT01761214 · Bacteriology and Inflammation in BronchiectasisGuangzhou Institute of Respiratory Disease · unknown · Bronchiectasis · principal investigator
- Ph4NCT01718340 · Effectiveness of Metformin in Recurrent Miscarriage in a Woman With HyperinsulinaemiaWoman's Health University Hospital, Egypt · withdrawn · Abortion, Habitual · principal investigator
- Ph3NCT01716572 · Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal BleedingHospital Universitari de Bellvitge · unknown · Gastrointestinal Hemorrhage, Hematemesis · principal investigator
- Ph4NCT01679561 · Intralipid Therapy for Recurrent Implantation Failure and Recurrent Miscarriages: Is it a Hope or Myth?A Randomized Clinical TrialWoman's Health University Hospital, Egypt · withdrawn · Pregnancy Complicated by Low Implantation · principal investigator
- Ph4NCT01670929 · Pr-conceptional Progesterone for Unexplained Recurrent MiscarriageWoman's Health University Hospital, Egypt · completed · Abortion, Habitual · principal investigator
- Ph2NCT01591577 · Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma MultiformeJonsson Comprehensive Cancer Center · completed · Newly Diagnosed Glioblastoma Multiforme · principal investigator
- Ph4NCT01580254 · Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle GlaucomaUniversity of Catanzaro · unknown · Intraocular Pressure (IOP), Tear Break-Up Time · principal investigator
- Ph2NCT01579578 · Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric CancerAstraZeneca · terminated · Metastatic, Gastric or Gastro-oesophageal Junction, Cancer · study director
- Ph4NCT01579331 · Reliability of Dynamic Contour Tonometry (DCT)University of Catanzaro · completed · Intraocular Pressure, Central Corneal Thickness · principal investigator
- Ph2NCT01576146 · Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary HyperparathyroidismKAI Pharmaceuticals · terminated · Secondary Hyperparathyroidism · study director
- N/ANCT01541501 · Comparison of Three Different No-contact PachymetriesUniversity of Catanzaro · unknown · Corneal Thickness · principal investigator
- Ph4NCT01540331 · Efficacy And Safety of Pneumatic TrabeculoplastyUniversity of Catanzaro · completed · Primary Open Angle Glaucoma · principal investigator
- Ph2NCT01426295 · Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the HospitalNantes University Hospital · completed · Hematologic Disease · principal investigator
- N/ANCT01381913 · Feasibility Trial of Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric CancerKagawa University · completed · Gastric Cancer, Chemoradiation · study director
- Ph3NCT01361997 · Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's ContaminationUniversidad de Guanajuato · completed · Infectious Diseases · principal investigator
- N/ANCT01349400 · Watchful Waiting Versus Repair of Oligosymptomatic Incisional HerniasCharite University, Berlin, Germany · completed · Incisional Hernia · principal investigator
- Ph3NCT01321125 · Chlorhexidine Against Sodium Hypochlorite as Skin AntisepticsUniversidad de Guanajuato · completed · Infectious Diseases · principal investigator
- Ph3NCT01305655 · Glucarpidase Effect on Severe Delayed HDM-clearance in Children Treated With High-dose Mtx in ALLNordic Society for Pediatric Hematology and Oncology · completed · Acute Lymphoblastic Leukemia (ALL) · principal investigator
- Ph4NCT01267487 · Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary BypassSANE-Society of Anesthesiology · completed · Cardiac Surgery, Cardiopulmonary Bypass, Anticoagulation · principal investigator
- Ph2NCT01254565 · Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismKAI Pharmaceuticals · completed · Secondary Hyperparathyroidism · study director
- Ph3NCT01220843 · FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney DiseaseCentre Hospitalier Universitaire, Amiens · completed · Chronic Renal Failure · principal investigator
- N/ANCT01219842 · Invasive Revascularization or Not in Intermittent ClaudicationSahlgrenska University Hospital · completed · Intermittent Claudication · principal investigator
- Ph3NCT01208922 · Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's DiarrhoeaDr. Falk Pharma GmbH · completed · Traveler's Diarrhea · principal investigator
- Ph1NCT01134549 · Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male VolunteersKAI Pharmaceuticals · completed · Hyperparathyroidism, Secondary · study director
- Ph1NCT01114152 · AZD9742 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese SubjectsAstraZeneca · completed · Healthy · principal investigator
- N/ANCT01051609 · Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer PatientsJonsson Comprehensive Cancer Center · completed · Breast Cancer · principal investigator
- Ph4NCT00981318 · Pilot Assessment of Lopinavir/Ritonavir and MaravirocRodwick, Barry M., M.D. · terminated · HIV Infections, Acquired Immunodeficiency Syndrome · principal investigator
- N/ANCT00938964 · Lidocaine For Neuroprotection During Cardiac SurgeryDuke University · completed · Cognitive Decline · principal investigator
- Ph1/Ph2NCT00852124 · Safety of VSL#3 in Adult AsthmaticsUniversity of Maryland, Baltimore · terminated · Asthma · principal investigator
- Ph3NCT00832039 · Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe SepsisKompetenznetz Sepsis · completed · Severe Sepsis, Septic Shock · study chair
- Ph4NCT00810524 · Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionSun Yat-sen University · unknown · Hepatitis B, Chronic · study director
- Ph1NCT00802217 · Oral Civamide Safety, Tolerability First in Human StudyWinston Laboratories · terminated · Healthy · study director
- Ph3NCT00738543 · Povidone-iodine Against Sodium Hypochlorite as Skin AntisepticsUniversidad de Guanajuato · completed · Healthy Volunteers · principal investigator
- N/ANCT00734344 · Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 InfectionUniversity of Alabama at Birmingham · completed · Acute HIV Infection · principal investigator
- Ph4NCT00721526 · Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety DisorderUniversity of New Mexico · completed · Alcohol Dependence, Anxiety Disorder · principal investigator
- Ph4NCT00676325 · Surgical Treatment To Greater Anterior Vaginal ProlapseFederal University of São Paulo · unknown · Hernia, Cystocele · principal investigator
- N/ANCT00672555 · Limberg-flap: Prospective Data CollectionCantonal Hospital of St. Gallen · completed · Pilonidal Sinus · principal investigator
- Early Ph1NCT00656552 · Safety and Efficacy of Escitalopram in the Treatment of Premature EjaculationCairo University · unknown · Premature Ejaculation · study chair
- Ph4NCT00638014 · Rapid Sternal Closure System (TALON)Duke University · completed · Sternal Wound Infection, Mediastinitis · principal investigator
- Ph1NCT00636519 · Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB MuscleEmergent BioSolutions · completed · Healthy Volunteers · principal investigator
- N/ANCT00616096 · Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE LevelsUniversity of Luebeck · completed · Dermatitis, Atopic · study chair
- Ph2/Ph3NCT00592904 · Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN)Eisai Inc. · completed · Neuralgia · study director
- N/ANCT00583050 · Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent GraftsThe Cleveland Clinic · completed · Thoracoabdominal Aneurysm, Abdominal Aortic Aneurysm · principal investigator
- Ph3NCT00528723 · Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled AsthmaChiesi Farmaceutici S.p.A. · completed · Bronchial Asthma · study director
- Ph3NCT00508131 · Effectiveness of Iron-Fortified Milk on Iron Status and Anemia in Young Children in MexicoInstituto Nacional de Salud Publica, Mexico · completed · Anemia, Iron Deficiency, Stunting · principal investigator
- Ph2NCT00508118 · NICardipine Neuroprotection in AortiC Surgery (NICNACS)Duke University · terminated · Aortic Aneurysm, Thoracic · principal investigator
- Ph2NCT00504725 · Ketamine In Thoracic Surgery (KITS) TrialDuke University · completed · Lung Cancer · principal investigator
- Ph1/Ph2NCT00494468 · Single Dose Pharmacokinetic and Pharmacodynamic Evaluation of Three Different Doses of Zolpidem in ChildrenEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · completed · Insomnia, Sleep Disorder · principal investigator
- N/ANCT00473369 · Prognosis of Atypical Pituitary AdenomasTohoku University · unknown · Pituitary Diseases · principal investigator
- Ph3NCT00473213 · Optimizing IFN Beta - 1B DoseUniversity of Turin, Italy · completed · Multiple Sclerosis · principal investigator
- N/ANCT00412269 · Healthy Transitions: Menopause Effect on Obesity, Energy Balance, and InsulinPennington Biomedical Research Center · completed · Menopause · principal investigator
- Ph1NCT00411931 · A Pharmacokinetics Study of MultiHance in Pediatric PatientsBracco Diagnostics, Inc · completed · Central Nervous System Pathology · study director
- N/ANCT00396188 · Screening Aid to Identify Corneas That May Have Pathologies or Other ConditionsCarl Zeiss Meditec, Inc. · completed · Corneal Diseases · principal investigator
- N/ANCT00386594 · Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's EsophagusRogers, B.H. Gerald, M.D. · terminated · Barrett Esophagus · principal investigator
- Ph4NCT00323102 · A Study Comparing Two Magnetic Resonance Imaging (MRI) Contrast Agents in MRI of the BrainBracco Diagnostics, Inc · completed · Brain Pathology · study director
- Ph3NCT00309062 · Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic RhinoconjunctivitisAllergopharma GmbH & Co. KG · completed · Birch Pollen Allergy · principal investigator
- Ph1/Ph2NCT00244348 · Hepatic Artery Infusion With OxaliplatinMedical College of Wisconsin · withdrawn · Colorectal Cancer, Metastasis, Liver Cancer · principal investigator
- Ph1/Ph2NCT00238420 · Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder CancerNational Cancer Institute (NCI) · completed · Bladder Urothelial Carcinoma, Stage I Bladder Cancer AJCC v6 and v7, Stage II Bladder Cancer AJCC v6 and v7 · principal investigator
- Ph4NCT00220896 · Prevention of Postoperative Delirium With DonepezilTechnical University of Munich · completed · Cognitively Normal Elderly Individuals · principal investigator
- Ph4NCT00118950 · Effect of Metformin Versus Repaglinide Treatment in Non-Obese Type 2 Diabetic Patients Uncontrolled by DietSteno Diabetes Center Copenhagen · completed · Diabetes Mellitus, Type 2 · study chair
- Ph4NCT00118937 · Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and DietSteno Diabetes Center Copenhagen · completed · Diabetes Mellitus, Type 1 · study chair
- N/ANCT00050284 · Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV InfectionNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- N/ANCT00050063 · Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV DrugsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections · study chair
- N/ANCT00046267 · Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected PatientsNational Institute of Allergy and Infectious Diseases (NIAID) · completed · HIV Infections, Hypercholesterolemia, Hypertriglyceridemia · study chair
- N/ANCT00006445 · Down Syndrome - Comparison of Screening Methods in the 1st and 2nd TrimestersEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · unknown · Down Syndrome, Chromosome Abnormalities · principal investigator
- N/ANCT00006165 · Native Hawaiian Diabetes Intervention ProgramNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · completed · Diabetes Mellitus, Type 2 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 295 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Department of Veterans Affairs Rehabilitation Research & Development Center for Limb Loss and MoBility (CLiMB)I50RX002357 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · fiscal years 2027Same name and institution; not confirmed by an ID
- Preventing youth interpersonal violence through improved implementation of wide-reaching, efficacious programs.R01CE003884 · NCIPC · NEW YORK UNIVERSITY · fiscal years 2027 · $399,998 awarded in 2027Same name and institution; not confirmed by an ID
- Senior Research Career ScientistIK6RX002970 · VA · VA PUGET SOUND HEALTHCARE SYSTEM · fiscal years 2027Same name and institution; not confirmed by an ID
- 1/5 Clinical Outcome Prediction of Psychosis from EHRs (COPPER)R01MH137679 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2026 · $921,159 awarded in 2026Same name and institution; not confirmed by an ID
- 2-Generation Interventions to Improve Cardiovascular Health in Indiana and Illinois Through Home Visiting (2-NOURISH)UH3HL163121 · NHLBI · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $951,711 awarded in 2026Same name and institution; not confirmed by an ID
- 3D intestinal organoid models to dissect the bidirectional relationship between gut barrier and HIV transcriptionR01DK146326 · NIDDK · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $811,941 awarded in 2026Same name and institution; not confirmed by an ID
- A randomized trial to determine impact, cost and cost effectiveness of pharmacy-based PrEP on PrEP continuation for women at high risk of HIVR01MH140751 · NIMH · CENTRE/SEXUAL HLTH/HIV AID RES/ZIMBABWE · fiscal years 2026 · $504,476 awarded in 2026Same name and institution; not confirmed by an ID
- A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults with CancerR37CA302422 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2026 · $672,904 awarded in 2026Same name and institution; not confirmed by an ID
- Accurate, low-cost, trackerless neuronavigation for transcranial magnetic stimulationR01MH129733 · NIMH · DUKE UNIVERSITY · fiscal years 2026 · $75,463 awarded in 2026Same name and institution; not confirmed by an ID
- Admin CoreU19AI089674 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $131,322 awarded in 2026Same name and institution; not confirmed by an ID
- Administrative Core AP01CA019014 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2026 · $145,686 awarded in 2026Same name and institution; not confirmed by an ID
- Advancing Digital Health Technology: A Summer Research Program for High School and Community College EducatorsR25EB038761 · NIBIB · UNIVERSITY OF NORTH TEXAS · fiscal years 2026 · $134,902 awarded in 2026Same name and institution; not confirmed by an ID
- Advancing population-based research on cognitive aging and dementia with minimally-invasive methods for quantifying biomarkers of neurocognitive functionR21AG101733 · NIA · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $440,000 awarded in 2026Same name and institution; not confirmed by an ID
- AI Driven Drug Discovery Pipeline for Lead Optimization: from Virtual Screening to Preclinical Validation of Brain-Penetrant AD TherapeuticsR01AG098161 · NIA · TRUSTEES OF INDIANA UNIVERSITY · fiscal years 2026 · $1,232,416 awarded in 2026Same name and institution; not confirmed by an ID
- An Analysis of ICE R391 Pathogen-encoded Rum DNA Polymerase in Generating Mutations Driving Rapid Acquisition of Antibiotic Drug Resistance in Diverse Recipient Bacterial SpeciesR01ES036941 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2026 · $535,315 awarded in 2026Same name and institution; not confirmed by an ID
- An Interdisciplinary Molecular Metabolism Training ProgramT32DK131958 · NIDDK · UNIVERSITY OF CHICAGO · fiscal years 2026 · $128,087 awarded in 2026Same name and institution; not confirmed by an ID
- Angiotensin-(1-7) and Cardiovascular Derangements in Obesity HypertensionR01HL170140 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · fiscal years 2026 · $706,467 awarded in 2026Same name and institution; not confirmed by an ID
- Annual meeting of the Vision Sciences SocietyR13EY037109 · NEI · NEW YORK UNIVERSITY · fiscal years 2026 · $67,500 awarded in 2026Same name and institution; not confirmed by an ID
- Augmenting Regulatory T Cell Reconstitution during GVHDR01HL179210 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · fiscal years 2026 · $675,405 awarded in 2026Same name and institution; not confirmed by an ID
- Basolateral brain endothelial cilia and its role in promoting vascular stabilityR01HL179583 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · fiscal years 2026 · $635,206 awarded in 2026Same name and institution; not confirmed by an ID
- Biochemically counteracting maladaptive functions of G9a/GLP in addictionR21DA062828 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $213,663 awarded in 2026Same name and institution; not confirmed by an ID
- Cancer Biology ProgramP30CA014236 · NCI · DUKE UNIVERSITY · fiscal years 2026 · $223,070 awarded in 2026Same name and institution; not confirmed by an ID
- Caveolin-1 contributes to the long-term function and structure of the neurovascular unit after juvenile concussionR01NS119605 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · fiscal years 2026 · $284,651 awarded in 2026Same name and institution; not confirmed by an ID
- Center on the Economics and Demography of AgingP30AG012839 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · fiscal years 2026 · $812,396 awarded in 2026Same name and institution; not confirmed by an ID
- Characterizing microvascular impairment in adults with elevated genetic risk for Alzheimer's DiseaseR01AG086263 · NIA · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2026 · $829,412 awarded in 2026Same name and institution; not confirmed by an ID
- Characterizing protein condensates and nuclear organization in genomic integrityR00GM151473 · NIGMS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · fiscal years 2026 · $249,000 awarded in 2026Same name and institution; not confirmed by an ID
- Circuit structure and dynamics in prefrontal-limbic networksR01MH116008 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · fiscal years 2026 · $535,833 awarded in 2026Same name and institution; not confirmed by an ID
- Clinical Spectrum and Societal Impact of Cognitive Impairment, Alzheimer's and Related Dementias among people with HIV in UgandaR01AG087790 · NIA · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2026 · $738,105 awarded in 2026Same name and institution; not confirmed by an ID
- Clonal hematopoiesis and inherited genetic variation in sickle cell diseaseR01HL168179 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $752,202 awarded in 2026Same name and institution; not confirmed by an ID
- Coagulation-inflammation crosstalk in placental abruptionR01HL163623 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · fiscal years 2026 · $575,724 awarded in 2026Same name and institution; not confirmed by an ID
- Community OHCA Risk Prediction Using Machine Learning: A Multi-Domain Approach to Prevention and PreparednessR01MD019007 · NIMHD · UNIVERSITY OF CHICAGO · fiscal years 2026 · $686,906 awarded in 2026Same name and institution; not confirmed by an ID
- Comparison of normal aging with Alzheimer's Disease: cellular, synaptic, and vascular indices affecting brain plasticity and neurogenesisR01AG080790 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · fiscal years 2026 · $736,852 awarded in 2026Same name and institution; not confirmed by an ID
- Consortium for food allergy research clinical center CoFarU01AI181964 · NIAID · BOSTON CHILDREN'S HOSPITAL · fiscal years 2026 · $380,000 awarded in 2026Same name and institution; not confirmed by an ID
- Continuous, Non-Invasive Optical Monitoring of Circulating Tumor Cell-Mediated Metastasis in Awake MiceR01CA260202 · NCI · NORTHEASTERN UNIVERSITY · fiscal years 2026 · $577,038 awarded in 2026Same name and institution; not confirmed by an ID
- Contributions of the Nasal Microbiome to Host Defense and Influenza Transmission - Project 2P01AI202707 · NIAID · DUKE UNIVERSITY · fiscal years 2026 · $626,156 awarded in 2026Same name and institution; not confirmed by an ID
- Core B: Organoid BiobankP01CA013106 · NCI · COLD SPRING HARBOR LABORATORY · fiscal years 2026 · $411,429 awarded in 2026Same name and institution; not confirmed by an ID
- Core H - Care Research CoreP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2026 · $317,189 awarded in 2026Same name and institution; not confirmed by an ID
- Core-002P01AI155393 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $195,848 awarded in 2026Same name and institution; not confirmed by an ID
- Deciphering the mechanisms underlying fibrotic remodeling of the bone marrow nicheR01HL181158 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · fiscal years 2026 · $794,042 awarded in 2026Same name and institution; not confirmed by an ID
- Deciphering the role of MLL-partial tandem duplication in AML through integrated genomic and proteomic approachesR01CA298151 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2026 · $699,587 awarded in 2026Same name and institution; not confirmed by an ID
- DECON: A sustained topical delivery platform to treat ocular inflammationR01EY034508 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · fiscal years 2026 · $398,369 awarded in 2026Same name and institution; not confirmed by an ID
- Defining the role of site-specific proteolysis in innate defense signalingR35GM147483 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · fiscal years 2026 · $412,500 awarded in 2026Same name and institution; not confirmed by an ID
- Development and Connectivity of the Circadian Clock Neuron NetworkR35GM161607 · NIGMS · TRUSTEES OF INDIANA UNIVERSITY · fiscal years 2026 · $415,822 awarded in 2026Same name and institution; not confirmed by an ID
- Diabetic Memory in Hematopoietic Stem CellsR01DK133145 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2026 · $436,663 awarded in 2026Same name and institution; not confirmed by an ID
- Discovery and evolution of mammalian Serpins as host-encoded viral protease inhibitorsR21AI190550 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2026 · $439,250 awarded in 2026Same name and institution; not confirmed by an ID
- Doctoral Training in Brain and Behavioral Development During Adolescence (UCLA BBDA)T32HD091059 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · fiscal years 2026 · $198,461 awarded in 2026Same name and institution; not confirmed by an ID
- Drug-gene-nutraceutical interactions of cannabidiolR01AT011463 · NCCIH · INDIANA UNIVERSITY INDIANAPOLIS · fiscal years 2026 · $425,080 awarded in 2026Same name and institution; not confirmed by an ID
- Dynamics of Multisensory Cue IntegrationR01EY008266 · NEI · NEW YORK UNIVERSITY · fiscal years 2026 · $393,100 awarded in 2026Same name and institution; not confirmed by an ID
- Effects of ICP elevation on NeuN Negative Membrane Disrupted NeuronsK00NS125825 · NINDS · DUKE UNIVERSITY · fiscal years 2026 · $92,744 awarded in 2026Same name and institution; not confirmed by an ID
- Elucidating the evolution of Krt8+ alveolar cells to Kras-mutant lung preneoplasia and cancerR01CA272863 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · fiscal years 2026 · $544,482 awarded in 2026Same name and institution; not confirmed by an ID
- Engineering best in class Acute Myeloid Leukemia (AML) CAR-T therapies by enhancing persistence and defining the immune landscape of AMLF31CA294978 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $42,520 awarded in 2026Same name and institution; not confirmed by an ID
- Enhancing Skeletal Muscle Recovery and Mitochondrial Function in Older Cancer SurvivorsR01AR087145 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · fiscal years 2026 · $401,625 awarded in 2026Same name and institution; not confirmed by an ID
- Environmental modifiers of UVR skin carcinogenesis: deciphering the effects of mixed exposuresR01ES038131 · NIEHS · STATE UNIVERSITY NEW YORK STONY BROOK · fiscal years 2026 · $813,303 awarded in 2026Same name and institution; not confirmed by an ID
- Environmental Resources for Individual Cognitive Health/Resilience (EnRICH)R01AG087199 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · fiscal years 2026 · $698,004 awarded in 2026Same name and institution; not confirmed by an ID
- Epigenetic alterations after DNA damage repair drive treatment resistance in glioblastomaK08CA263302 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2026 · $142,007 awarded in 2026Same name and institution; not confirmed by an ID
- Epigenetic Regulation of Heart Failure with Preserved Ejection FractionR01HL174996 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · fiscal years 2026 · $671,064 awarded in 2026Same name and institution; not confirmed by an ID
- Exploring the Impact of Base Deaminase Deregulation on Precancer EvolutionR01CA296974 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2026 · $445,092 awarded in 2026Same name and institution; not confirmed by an ID
- Far-red Microscopy for Deep Voltage Imaging of Large Neuronal PopulationsR01NS147518 · NINDS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · fiscal years 2026 · $595,774 awarded in 2026Same name and institution; not confirmed by an ID
- FOcal Cerebral Arteriopathy Steroids (FOCAS) TrialUH3NS119702 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $1,535,323 awarded in 2026Same name and institution; not confirmed by an ID
- Functional and Molecular Characterization of Epithelial Subtypes in Cervical Remodeling and Preterm BirthR01HD110147 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2026 · $626,998 awarded in 2026Same name and institution; not confirmed by an ID
- Gegoo myaajyang gkendmang (Knowing what we eat): Reducing Exposure to Dietary Contaminant Mixtures by Supporting Great Lakes Subsistence Food ProgramsR01ES039042 · NIEHS · MEDICAL COLLEGE OF WISCONSIN · fiscal years 2026 · $706,420 awarded in 2026Same name and institution; not confirmed by an ID
- Gene regulatory network modeling of disease-associated DNA methylation perturbationsR01AI173314 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · fiscal years 2026 · $740,330 awarded in 2026Same name and institution; not confirmed by an ID
- GEneration and assessment of Multi-omic informed Subtypes of Type 2 Diabetes (GEMS-T2D)U01DK140757 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2026 · $779,939 awarded in 2026Same name and institution; not confirmed by an ID
- Genetic determinants of AAV liver transduction and toxicityR01DK142742 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2026 · $763,647 awarded in 2026Same name and institution; not confirmed by an ID
- Glucose & oxygen metabolism regulate human cortical progenitor development impacting brain healthR01NS146341 · NINDS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · fiscal years 2026 · $549,397 awarded in 2026Same name and institution; not confirmed by an ID
- HERITABLE, EPIGENETIC EFFECTS OF PATERNAL ALCOHOL USE ON FASD PHENOTYPESR01AA028219 · NIAAA · TEXAS A&M AGRILIFE RESEARCH · fiscal years 2026 · $607,064 awarded in 2026Same name and institution; not confirmed by an ID
- Heterogeneity in Treatment Effect Timing in Geriatrics and Palliative Care StudiesI01HX003602 · VA · VA BOSTON HEALTH CARE SYSTEM · fiscal years 2026Same name and institution; not confirmed by an ID
- HISPANIC COMMUNITY HEALTH STUDY - STUDY OF LATINOS (HCHS-SOL) CHICAGO FIELD CENTER - TASK AREA A - CORE STUDY OPERATIONS75N92025D00 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · fiscal years 2026 · $1,589,922 awarded in 2026Same name and institution; not confirmed by an ID
- Homeostatic Neuroprotection in the Aging Nervous SystemR01AG081252 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $615,633 awarded in 2026Same name and institution; not confirmed by an ID
- Host factors in Shigella flexneri infectionR01AI081724 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2026 · $575,734 awarded in 2026Same name and institution; not confirmed by an ID
- Human Virome Characterization Center for the Oral-Gut-Brain AxisU54AG089335 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · fiscal years 2026 · $811,998 awarded in 2026Same name and institution; not confirmed by an ID
- Human/Animal ExposureP30ES005022 · NIEHS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · fiscal years 2026 · $73,444 awarded in 2026Same name and institution; not confirmed by an ID
- Humanity Unlocking Biomaterials (HUB) Coordinating CenterU24EB035897 · NIBIB · UNIVERSITY OF ILLINOIS AT CHICAGO · fiscal years 2026 · $2,164,337 awarded in 2026Same name and institution; not confirmed by an ID
- Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled TrialU01DK134321 · NIDDK · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $2,478,728 awarded in 2026Same name and institution; not confirmed by an ID
- Impact of Dual Enrollment in the VA and Medicare Advantage on Care and Outcomes for VeteransI01HX003893 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · fiscal years 2026Same name and institution; not confirmed by an ID
- IMPILO: Investigating novel 6-Month regimens for RR-TB in Pregnancy and LactationR01AI183355 · NIAID · MEDICAL RESEARCH COUNCIL OF SOUTH AFRICA · fiscal years 2026 · $120,689 awarded in 2026Same name and institution; not confirmed by an ID
- Implementing a Social Determinants of Health Screening and Referral Care Model in the Neonatal Intensive Care UnitR01HD104772 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · fiscal years 2026 · $666,861 awarded in 2026Same name and institution; not confirmed by an ID
- In Vivo Imaging and Post-Mortem Study of Methamphetamine Use on Immune Dysfunction and HIV Reservoir Transcription among People with HIV on ARTRM1DA063218 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $2,335,360 awarded in 2026Same name and institution; not confirmed by an ID
- Induction and Evolution of Metaplasia in the StomachR01DK101332 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $535,314 awarded in 2026Same name and institution; not confirmed by an ID
- Inflammasomes - a driver of sexual dimorphism to glioma therapiesR01NS141861 · NINDS · DUKE UNIVERSITY · fiscal years 2026 · $406,958 awarded in 2026Same name and institution; not confirmed by an ID
- Influence of viral and immune interventions on early events following oral SIV infectionR01DE032663 · NIDCR · SEATTLE CHILDREN'S HOSPITAL · fiscal years 2026 · $798,372 awarded in 2026Same name and institution; not confirmed by an ID
- INFUSE HFPEFR01AG097715 · NIA · DUKE UNIVERSITY · fiscal years 2026 · $680,818 awarded in 2026Same name and institution; not confirmed by an ID
- Integrated host-microbe metagenomic sequencing to improve diagnosis, prognostication, and subphenotyping of complications following lung transplantation.K23HL181314 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $200,880 awarded in 2026Same name and institution; not confirmed by an ID
- Integrating liquid biopsy-based epigenetic and imaging modalities to evaluate disease response in multiple myelomaR01CA280637 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2026 · $643,069 awarded in 2026Same name and institution; not confirmed by an ID
- Integrating Maternal and Child Health Services: Development and Pilot Testing of a Pediatric Clinic-Based Postpartum Contraception InterventionK23HD113841 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $170,748 awarded in 2026Same name and institution; not confirmed by an ID
- Integrating simplicial complex structures into statistical models for brain healthR01MH141931 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · fiscal years 2026 · $831,656 awarded in 2026Same name and institution; not confirmed by an ID
- Integrative Multi-Genomics Approach of the Cortico-Mesolimbic System to Study the Neurobiological Causes forSuicide in Veterans.I01BX007250 · VA · PHOENIX VA HEALTH CARE SYSTEM · fiscal years 2026Same name and institution; not confirmed by an ID
- Intersecting clinical, genomic, and experimental investigation to understand the mechanisms and impact of coronary artery patterningR01HL171326 · NHLBI · PALO ALTO VETERANS INSTIT FOR RESEARCH · fiscal years 2026 · $633,955 awarded in 2026Same name and institution; not confirmed by an ID
- Investigation of the Mechanism(s) of Beta and Delta Cell Coordination Under High GlucoseF30DK138710 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 2026 · $55,114 awarded in 2026Same name and institution; not confirmed by an ID
- Irvine Summer Institute in Biostatistics and Data ScienceR25AI170491 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · fiscal years 2026 · $229,134 awarded in 2026Same name and institution; not confirmed by an ID
- IUSM TREAT-AD CenterU54AG065181 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · fiscal years 2026 · $8,319,175 awarded in 2026Same name and institution; not confirmed by an ID
- KUH-TN Networking CoreU2CDK129440 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · fiscal years 2026 · $78,451 awarded in 2026Same name and institution; not confirmed by an ID
- Leadership, Planning and EvaluationP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · fiscal years 2026 · $116,339 awarded in 2026Same name and institution; not confirmed by an ID
- Leveraging doxorubicin immune-modulation, blood-brain barrier opening, and personalized medicine for effective immunotherapy in glioblastoma. A mechanistic approach and pharmacokinetic trial.U19CA264338 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $765,563 awarded in 2026Same name and institution; not confirmed by an ID
- Liquid Biopsy CoreP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2026 · $204,368 awarded in 2026Same name and institution; not confirmed by an ID
- Lysine Methylation as a Novel Regulatory Mechanism of HPV E2 FunctionR21AI199466 · NIAID · MARIAN UNIVERSITY · fiscal years 2026 · $208,880 awarded in 2026Same name and institution; not confirmed by an ID
- Matrix Regenerative Nanotherapeutic Platform for Pelvic Organ ProlapseR01HD119910 · NICHD · CLEVELAND CLINIC LERNER COM-CWRU · fiscal years 2026 · $657,473 awarded in 2026Same name and institution; not confirmed by an ID
- Mechanisms of amplification and nonlinearity in the mouse cochleaR01DC021006 · NIDCD · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2026 · $415,000 awarded in 2026Same name and institution; not confirmed by an ID
- Mechanisms of fibrosis and remodeling in arrhythmogenic mitral valve prolapseF31HL184812 · NHLBI · TEXAS ENGINEERING EXPERIMENT STATION · fiscal years 2026 · $47,431 awarded in 2026Same name and institution; not confirmed by an ID
- Medical Health Research Career Scientist Award ApplicationIK6RD001331 · VA · NORTHPORT VA MEDICAL CENTER · fiscal years 2026Same name and institution; not confirmed by an ID
- Mentoring in Musculoskeletal Pain PhenotypesK24AR079594 · NIAMS · DUKE UNIVERSITY · fiscal years 2026 · $182,476 awarded in 2026Same name and institution; not confirmed by an ID
- Metabolic age to define influences of the lipidome on brain aging in Alzheimer's diseaseR01AG081322 · NIA · DUKE UNIVERSITY · fiscal years 2026 · $157,161 awarded in 2026Same name and institution; not confirmed by an ID
- Microglial immunity in Toxoplasmic encephalitisR21AI189465 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · fiscal years 2026 · $191,886 awarded in 2026Same name and institution; not confirmed by an ID
- Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertensionR01HL162960 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2026 · $759,113 awarded in 2026Same name and institution; not confirmed by an ID
- Molecular and Neural Mechanisms of Temperature Preference Rhythm in DrosophilaR35GM152154 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 2026 · $402,500 awarded in 2026Same name and institution; not confirmed by an ID
- Molecular characterization of human pregnancy-induced cervical epitheliumR21HD118291 · NICHD · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2026 · $456,500 awarded in 2026Same name and institution; not confirmed by an ID
- Molecular Regulation of the Kappa Opioid Receptor by 14-3-3 gammaK99DA060953 · NIDA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · fiscal years 2026 · $163,350 awarded in 2026Same name and institution; not confirmed by an ID
- Motion Compensated fMRI for Pre-Surgical Planning in EpilepsyR01NS124212 · NINDS · BOSTON CHILDREN'S HOSPITAL · fiscal years 2026 · $665,210 awarded in 2026Same name and institution; not confirmed by an ID
- MR Metabolic Imaging of Multiple SclerosisR01NS102156 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $443,937 awarded in 2026Same name and institution; not confirmed by an ID
- Multi-omic Investigation of the Gut–Liver Axis in HIV-related Liver DiseaseK23DK149857 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $194,076 awarded in 2026Same name and institution; not confirmed by an ID
- Multinuclear MRI to Monitor Breast Cancer TherapyR01CA266345 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2026 · $702,954 awarded in 2026Same name and institution; not confirmed by an ID
- Neural stem cell rejuvenation through single cell pharmacogenomicsR01AG076956 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2026 · $738,890 awarded in 2026Same name and institution; not confirmed by an ID
- Neuronal Targets and Mechanisms of Manganese NeurotoxicityR01ES024812 · NIEHS · UNIVERSITY OF TEXAS AT AUSTIN · fiscal years 2026 · $610,233 awarded in 2026Same name and institution; not confirmed by an ID
- New technologies to identify molecular regulators of the human hippocampus neurogenic niche in healthy aging and Alzheimer's DiseaseR01AG076949 · NIA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · fiscal years 2026 · $799,804 awarded in 2026Same name and institution; not confirmed by an ID
- NIDA Clinical Trials Network: Big South/West NodeUG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · fiscal years 2026 · $5,664,411 awarded in 2026Same name and institution; not confirmed by an ID
- North American Testis Workshop 2026R13HD122397 · NICHD · UNIVERSITY OF HAWAII AT MANOA · fiscal years 2026 · $20,000 awarded in 2026Same name and institution; not confirmed by an ID
- Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular diseaseR01DK131104 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $490,258 awarded in 2026Same name and institution; not confirmed by an ID
- Omic Approaches to Factor VIII Inhibitor Development in Hemophilia Patients of Mexican DescentR01HL169763 · NHLBI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · fiscal years 2026 · $658,485 awarded in 2026Same name and institution; not confirmed by an ID
- Optimizing an Adaptive Self-care Support Intervention for Adults with Type 2 Diabetes Leveraging their Social RelationshipsK23DK140531 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $186,624 awarded in 2026Same name and institution; not confirmed by an ID
- Optimizing medication use and support among people with dementia who live aloneK76AG088411 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $242,805 awarded in 2026Same name and institution; not confirmed by an ID
- Optimizing TCR-CD3 signaling for immunotherapy of cancerR01CA284604 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2026 · $635,940 awarded in 2026Same name and institution; not confirmed by an ID
- Palm Springs Symposia on HIV/AIDSR13AI198104 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · fiscal years 2026 · $50,000 awarded in 2026Same name and institution; not confirmed by an ID
- Perfusion CT for liver radioembolizationR21CA300717 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 2026 · $409,141 awarded in 2026Same name and institution; not confirmed by an ID
- Pilot CoreP60AA007611 · NIAAA · INDIANA UNIVERSITY INDIANAPOLIS · fiscal years 2026 · $144,070 awarded in 2026Same name and institution; not confirmed by an ID
- Posttranslational modifications of glucocorticoid receptor associated with drug-resistance in prostate cancerR01CA290402 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · fiscal years 2026 · $619,134 awarded in 2026Same name and institution; not confirmed by an ID
- Precision cancer microsurgery using laser ablation-cooling with pulse burstsR01CA296584 · NCI · NORTHEASTERN UNIVERSITY · fiscal years 2026 · $86,222 awarded in 2026Same name and institution; not confirmed by an ID
- Predicting phenotypes in benign urologyR01DK138121 · NIDDK · DUKE UNIVERSITY · fiscal years 2026 · $661,506 awarded in 2026Same name and institution; not confirmed by an ID
- Prefrontal-cingulate functional networks in aging monkeys: neural circuit substrates of cognitive agingR01AG083206 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · fiscal years 2026 · $771,466 awarded in 2026Same name and institution; not confirmed by an ID
- Probing network-specific cortical connectivity by combining multifocal transcranial magnetic stimulation with electroencephalographyK01MH138823 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · fiscal years 2026 · $183,190 awarded in 2026Same name and institution; not confirmed by an ID
- Processes and circuitry underlying threat sensitivity as a treatment target for comorbid anxiety and depressionR01MH132565 · NIMH · LAUREATE INSTITUTE FOR BRAIN RESEARCH · fiscal years 2026 · $424,594 awarded in 2026Same name and institution; not confirmed by an ID
- Project 1: Human and Non-human Primate Influenza B-cell RepertoiresP01AI089618 · NIAID · BOSTON CHILDREN'S HOSPITAL · fiscal years 2026 · $710,000 awarded in 2026Same name and institution; not confirmed by an ID
- Project 2 Title: Diabetes, RAGE/DIAPH1 and Limb IschemiaP01HL187163 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2026 · $549,096 awarded in 2026Same name and institution; not confirmed by an ID
- Project 2: The Intersection of Telehealth and Health Disparities in At-Risk Older Patients with CancerU54CA285117 · NCI · SAN DIEGO STATE UNIVERSITY · fiscal years 2026 · $314,679 awarded in 2026Same name and institution; not confirmed by an ID
- Protein-RNA interactions in cancerR01CA264986 · NCI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · fiscal years 2026 · $688,625 awarded in 2026Same name and institution; not confirmed by an ID
- Quality Improvement in time to Treatment of Status Epilepticus (QuITT-SE)R01NS133037 · NINDS · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · fiscal years 2026 · $639,809 awarded in 2026Same name and institution; not confirmed by an ID
- Quantitative imaging of choroid plexus function and neurofluid circulation in Alzheimer's Disease Related DementiaR01AG083159 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $580,371 awarded in 2026Same name and institution; not confirmed by an ID
- Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: Cognition (ROMA:Cog)R01NS123639 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2026 · $33,923 awarded in 2026Same name and institution; not confirmed by an ID
- Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)R01AI143340 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $362,774 awarded in 2026Same name and institution; not confirmed by an ID
- Rapid Research for Diagnostics Development in TB Network: Episode 2 (R2D2 TB Network II)R01AI190419 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $2,098,147 awarded in 2026Same name and institution; not confirmed by an ID
- Recent Advances in HIV ResearchR13AI102630 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $20,000 awarded in 2026Same name and institution; not confirmed by an ID
- Recruiting and retaining participants from disadvantaged neighborhoods in registriesR01AG077628 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · fiscal years 2026 · $715,679 awarded in 2026Same name and institution; not confirmed by an ID
- Regulation of Adenylyl Cyclase Signaling PathwaysR35GM145291 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2026 · $413,400 awarded in 2026Same name and institution; not confirmed by an ID
- Regulation of intestinal NaCl absorptionI01BX003443 · VA · HUNTINGTON VETERANS AFFAIRS MED CTR · fiscal years 2026Same name and institution; not confirmed by an ID
- Renewal of The Mid-America CTSA Consortium (MACC) as a Regional Clinical Center for SIRENU24NS129486 · NINDS · UNIVERSITY OF CHICAGO · fiscal years 2026 · $382,861 awarded in 2026Same name and institution; not confirmed by an ID
- Research Capacity Building CoreU54CA284109 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · fiscal years 2026 · $191,376 awarded in 2026Same name and institution; not confirmed by an ID
- Restoring α1,2-Fucose to Rebuild the Microbiota and Strengthen the Intestinal Barrier in HIVR01DK149864 · NIDDK · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $794,032 awarded in 2026Same name and institution; not confirmed by an ID
- Reversing cancer immunosuppression using attenuated Listeria monocytogenesR01CA283604 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · fiscal years 2026 · $473,641 awarded in 2026Same name and institution; not confirmed by an ID
- Role of isoLGs and neutrophils in psoriasis-induced renal dysfunction and hypertensionP01HL174442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · fiscal years 2026 · $479,089 awarded in 2026Same name and institution; not confirmed by an ID
- Same-day PrEP Engagement in the Emergency Department (SPEED PrEP)R01AI207134 · NIAID · UNIVERSITY OF CHICAGO · fiscal years 2026 · $853,906 awarded in 2026Same name and institution; not confirmed by an ID
- Scholars in Oncology Associated Research (SOAR)R25CA240134 · NCI · UNIVERSITY OF CHICAGO · fiscal years 2026 · $165,257 awarded in 2026Same name and institution; not confirmed by an ID
- Scripps Center for Oceans and Human Health: advancing the science of marine contaminants and seafood securityP01ES035541 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · fiscal years 2026 · $601,361 awarded in 2026Same name and institution; not confirmed by an ID
- SDSU FUERTE: Administrative CoreU54CA267789 · NCI · SAN DIEGO STATE UNIVERSITY · fiscal years 2026 · $60,201 awarded in 2026Same name and institution; not confirmed by an ID
- Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in IndiaR01CA285063 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · fiscal years 2026 · $341,510 awarded in 2026Same name and institution; not confirmed by an ID
- Sensory Augmentation, Restoration, and Modulation Using a Spinal NeuroprosthesisDP2NS136872 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2026 · $877,602 awarded in 2026Same name and institution; not confirmed by an ID
- Serologic measures of enteric pathogen transmission for intervention studies and population monitoring in low-resource settingsR01AI166671 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $435,028 awarded in 2026Same name and institution; not confirmed by an ID
- Sex differences in the effects of prior social isolation stress on stroke outcomesF30NS131053 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · fiscal years 2026 · $47,170 awarded in 2026Same name and institution; not confirmed by an ID
- SHE (Summer Healthcare Experience) in OncologyR25GM154352 · NIGMS · UNIVERSITY OF CHICAGO · fiscal years 2026 · $260,048 awarded in 2026Same name and institution; not confirmed by an ID
- Simultaneous Imaging of Tissue Biochemistry and Metabolism associated with Biomechanics in Patella Femoral Joint OsteoarthritisR01AR079647 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $640,291 awarded in 2026Same name and institution; not confirmed by an ID
- Size Exclusion Chromatography-Multi Angle Light Scattering (SEC-MALS) for Enhancing Biomedical Research and Education at Fresno StateS10GM164793 · NIGMS · CALIFORNIA STATE UNIVERSITY FRESNO · fiscal years 2026 · $250,000 awarded in 2026Same name and institution; not confirmed by an ID
- Social Determinants of Health, Resilience, and Premature Cognitive Aging in End-stage Renal DiseaseR01AG077888 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2026 · $789,118 awarded in 2026Same name and institution; not confirmed by an ID
- Social Networks and Cognitive Health among Black and Latino sexual minority men in NJRF1AG089099 · NIA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · fiscal years 2026 · $2,122,144 awarded in 2026Same name and institution; not confirmed by an ID
- Social networks and risk of delayed arrival to the hospital during strokeR01MD016178 · NIMHD · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2026 · $733,948 awarded in 2026Same name and institution; not confirmed by an ID
- Statistical Methods for Integrative Genomics in CancerP01CA196569 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2026 · $2,554,389 awarded in 2026Same name and institution; not confirmed by an ID
- Sulfotyrosine, an essential determinant for diverse protein-protein interactionsR35GM148173 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · fiscal years 2026 · $425,168 awarded in 2026Same name and institution; not confirmed by an ID
- Supporting, Promoting, and Launching the Expansion of Nutrition, Diabetes, and Obesity Researchers in North CarolinaU24DK132715 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · fiscal years 2026 · $875,955 awarded in 2026Same name and institution; not confirmed by an ID
- Synthetic biology tools and strategies to streamline the sensing and responding to disease cues in engineered theragnostic bacteria.R35GM156762 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · fiscal years 2026 · $402,500 awarded in 2026Same name and institution; not confirmed by an ID
- Synthetic Genetic Controller Circuits for Transcription Factor-Directed DifferentiationR01EB038310 · NIBIB · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · fiscal years 2026 · $678,583 awarded in 2026Same name and institution; not confirmed by an ID
- The Columbia University Training Program in Lung ScienceT32HL105323 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2026 · $440,144 awarded in 2026Same name and institution; not confirmed by an ID
- The critical journey: the role of clade and an adhesin in Leptospira kidney colonizationR21AI196394 · NIAID · MEDICAL COLLEGE OF WISCONSIN · fiscal years 2026 · $429,000 awarded in 2026Same name and institution; not confirmed by an ID
- The Fibrosis-Immunity Interface in Corneal TransplantationR01EY037257 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · fiscal years 2026 · $545,532 awarded in 2026Same name and institution; not confirmed by an ID
- The mF2F Program: Bridging Digital Innovations and Trauma Care to Boost Health-Related Quality of Life among Black MenP20GM156709 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2026 · $223,760 awarded in 2026Same name and institution; not confirmed by an ID
- The Postpartum Assessment of Health Survey (PAHS)R01MD017460 · NIMHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2026 · $645,930 awarded in 2026Same name and institution; not confirmed by an ID
- The Risk of Acquired Neonatal Significant brain Injury during perinatal Transition in Congenital Heart Disease: TRANSIT CHD studyR01NS125404 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $435,857 awarded in 2026Same name and institution; not confirmed by an ID
- The role of BNST PKCdelta neurons in compulsive ethanol intakeK99AA031509 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · fiscal years 2026 · $156,644 awarded in 2026Same name and institution; not confirmed by an ID
- The Role of Tufts Cells in Salivary Gland ImmunityR00DE032363 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · fiscal years 2026 · $245,440 awarded in 2026Same name and institution; not confirmed by an ID
- The Safety of Switching Between Complex Branded and Generic Drugs: Developing a Semi-Automated Sequential Surveillance System Using Tree-Based Scan StatisticsU01FD008316 · FDA · BRIGHAM AND WOMEN'S HOSPITAL · fiscal years 2026 · $499,681 awarded in 2026Same name and institution; not confirmed by an ID
- The Wisconsin Research and Education Network (WREN): Expanding Research Capacity in Rural Primary Care ClinicsOT2OD038373 · OD · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2026 · $2,066,174 awarded in 2026Same name and institution; not confirmed by an ID
- TNF alpha and Recovery from Alcoholic Liver InjuryR01AA010154 · NIAAA · DUKE UNIVERSITY · fiscal years 2026 · $582,893 awarded in 2026Same name and institution; not confirmed by an ID
- Training Health Equity ScholaRs in InnoVation, PrEvention, and Social Impact (THRIVES) Fellowship ProgramT32HL175782 · NHLBI · UNIVERSITY OF CALIFORNIA BERKELEY · fiscal years 2026 · $332,131 awarded in 2026Same name and institution; not confirmed by an ID
- U-RISE at the New Jersey Institute of TechnologyT34GM145521 · NIGMS · NEW JERSEY INSTITUTE OF TECHNOLOGY · fiscal years 2026 · $414,804 awarded in 2026Same name and institution; not confirmed by an ID
- Uncovering the Function and Protein Subcellular Localization of Bicistronic Loci in Auxenochlorella protothecoidesF31GM157804 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · fiscal years 2026 · $47,105 awarded in 2026Same name and institution; not confirmed by an ID
- Understanding Vision Impairment in ESKD to Prevent Cognitive Impairment and Dementia/Alzheimer’s disease: the VIS-HD Cohort StudyR01AG086252 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2026 · $825,065 awarded in 2026Same name and institution; not confirmed by an ID
- Unraveling the Biosynthesis of Aromatic Virulence Factors in Pseudomonas aeruginosaR15AI188433 · NIAID · EASTERN WASHINGTON UNIVERSITY · fiscal years 2026 · $470,978 awarded in 2026Same name and institution; not confirmed by an ID
- UTMB Claude D. Pepper Older Americans Independence CenterP30AG024832 · NIA · UNIVERSITY OF TEXAS MED BR GALVESTON · fiscal years 2026 · $1,291,186 awarded in 2026Same name and institution; not confirmed by an ID
- VA Aripiprazole vs. Esketamine for Treatment of Depression VAST-D III01CX002191 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · fiscal years 2026Same name and institution; not confirmed by an ID
- Virginia Division of Consolidated Laboratory Services Laboratory Flexible Funding ModelU19FD008604 · FDA · VA DIVISION/CONSOLIDATED LAB SRVS · fiscal years 2026 · $1,147,327 awarded in 2026Same name and institution; not confirmed by an ID
- Virology Core Laboratory (VCL)75N93025C00 · NIAID · DUKE UNIVERSITY · fiscal years 2026 · $958,721 awarded in 2026Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- NRG Oncology Network Group Operations CenterU10CA180868 · NCI · NRG ONCOLOGY FOUNDATION, INC. · PI Quynh-Thu Xuan Le, ROBERT S. MANNEL, NORMAN WOLMARK · fiscal years 2014 to 2026Named on NCT04037254, NCT00238420
- Lidocaine for Neuroprotection During Cardiac SurgeryR01HL096978 · NHLBI · DUKE UNIVERSITY · PI Joseph P Mathew · fiscal years 2009 to 2013Named on NCT00938964
- VSL for AsthmaR21AT004089 · NCCIH · UNIVERSITY OF MARYLAND BALTIMORE · PI Alessio Fasano · fiscal years 2008 to 2009Named on NCT00852124
- A Program of Research and Mentorship on Alcoholism and Co-occuring DisordersK24AA016555 · NIAAA · UNIVERSITY OF NEW MEXICO · PI Michael Parks Bogenschutz · fiscal years 2007 to 2011Named on NCT00721526
- Radiation Therapy Oncology GroupU10CA021661 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI Walter J. Curran · fiscal years 1985 to 2013Named on NCT00238420
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.